Literature DB >> 8297642

The chemotherapy of colon cancer can no longer be ignored.

D Cunningham1, M Findlay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8297642     DOI： 10.1016/0959-8049(93)90036-f

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  10 in total

Review 1.  Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer.

Authors:  Mario Kopljar; Leonardo Patrlj; Zeljko Bušić; Marijan Kolovrat; Mislav Rakić; Robert Kliček; Marcel Zidak; Igor Stipančić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Targeted therapies in colorectal cancer: surgical considerations.

Authors:  Carrie Luu; Amanda K Arrington; Hans F Schoellhammer; Gagandeep Singh; Joseph Kim
Journal:  J Gastrointest Oncol       Date:  2013-09

3.  Responsiveness of CPT-11 in respect to hMLH1 and hMSH2 protein expression in the primary colorectal cancer.

Authors:  In Ja Park; Hee Cheol Kim; Chang Sik Yu; Heung Moon Chang; Jea Hwan Lee; Jong Hoon Kim; Tae Won Kim; Jung Sun Kim; Jin Cheon Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

Review 4.  Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.

Authors:  P C Simmonds
Journal:  BMJ       Date:  2000-09-02

6.  Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.

Authors:  Xiao-yan Tang; You-qing Zhu; Wen-hui Tao; Bai Wei; Xiao-ling Lin
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

7.  The novel highly lipophilic topoisomerase I inhibitor DB67 is effective in the treatment of liver metastases of murine CT-26 colon carcinoma.

Authors:  Lluis A Lopez-Barcons; Junhong Zhang; Gunching Siriwitayawan; Thomas G Burke; Roman Perez-Soler
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

8.  Progress in preventing death from colorectal cancer.

Authors:  P Boyle
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

9.  Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.

Authors:  H J Schneider; S A Sampson; D Cunningham; A R Norman; H J Andreyev; J V Tilsed; P A Clarke
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer.

Authors:  J Gaulin; R Kotb; E Turcotte; G Berard; B Sawan; G Schmutz; P Beauregard
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.